HAVING A BALANCED MIX OF ONLINE & IN-PERSON MENTORING, PROFESSIONAL DEVELOPMENT AND SECOND OPINIONS
With
Dr Kieran Richardson (FACP)
Specialist Musculoskeletal Physiotherapist &
Director, Global Specialist Physiotherapy Pty Ltd
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Perth | October 2025
Dr. Kieran Richardson (FACP) is a Specialist Physiotherapist, conferred by the Australian College of Physiotherapists (Australian Physiotherapy Association) in 2016.
Dr Richardson is the Director of Global Specialist Physiotherapy, a consultancy company providing online Formal Mentoring and Professional Development individual clinicians, clinics, and groups, as well as Second Opinions to clinicians and directly to patients all around the world.
He has presented in state, national and international conferences, and has a special interest in evidence-based, non-surgical management of musculoskeletal conditions and recognition of these strategies within the Physiotherapy profession, as well as interprofessionally and to the general public.
Since the COVID-19 pandemic, his clinical role within Global Specialist Physiotherapy has shifted, whereby now he and his team offer primarily telehealth non-surgical second opinion consultations for patients with pain and injury locally in Australia and around the world.
He has conducted research into the biopsychosocial nature of musculoskeletal pain and injury, online information about the management of anterior cruciate ligament ruptures in Australia and is currently a part of an expert group of clinicians assisting the Australian Knee Injury Study through La Trobe University in Victoria.
Source: Supplied
-
Pathology technology at a crossroads
The CEO of Pathology Technology Australia, Dean Whiting spoke with Australian Health Journal about the following:
– Pathology Technology Australia’s key priorities in the coming years
– Current local capability in pathology technology compared to other countries
– How the health system supports change and adoption of pathology technology
– How pathology is perceived by the public and in government as well as how developments in pathology technology are followed and understood
– Observations in the Strengthening Medicare Taskforce ReportIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
Navigating the health system for mental health support
Senior professionals and middle managers are experiencing increased burnout and stress, leading to higher alcohol consumption, and there is a need for better support and resources for mental health and addiction treatment in Australia, according to Ruth Limkin, Founder of The Banyans and Chief Development Officer at parent Sana Health Group.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
